Page last updated: 2024-12-07

1-cyclohexylthymine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1-Cyclohexylthymine is a modified nucleoside, specifically a **thymine analog**. It's important to understand that thymine is one of the four nitrogenous bases found in DNA, and thymine analogs are synthetic molecules that share structural similarities with thymine, leading to interesting interactions with DNA and other biological systems.

Here's what makes 1-cyclohexylthymine significant in research:

**1. Antiviral Properties:**

* 1-Cyclohexylthymine has shown potent antiviral activity against viruses like herpes simplex virus (HSV), which causes cold sores and genital herpes. This antiviral activity stems from its ability to inhibit viral DNA polymerase, an enzyme essential for viral replication.

**2. Potential as an Anticancer Agent:**

* Due to its structural resemblance to thymine, 1-Cyclohexylthymine can be incorporated into DNA, potentially disrupting its structure and function. This property makes it a promising candidate for anticancer therapy, as it could interfere with the growth and proliferation of cancer cells.

**3. Investigating DNA Structure and Function:**

* Researchers use modified nucleosides like 1-Cyclohexylthymine to study DNA structure and how it interacts with various proteins. By introducing these analogs into DNA, scientists can gain insights into the complex processes of DNA replication, repair, and transcription.

**4. Building Blocks for Novel Therapeutics:**

* 1-Cyclohexylthymine and similar analogs serve as starting points for designing novel antiviral, anticancer, and other therapeutic agents. By modifying their structure, researchers can fine-tune their properties to achieve specific therapeutic goals.

**Important Note:** 1-Cyclohexylthymine is still in the research stage and has not yet been approved for clinical use. Further research is needed to fully understand its potential benefits and safety profile.

In summary, 1-Cyclohexylthymine is a valuable tool for researchers in various fields, offering potential benefits for antiviral and anticancer treatments, as well as furthering our understanding of DNA structure and function.

Cross-References

ID SourceID
PubMed CID96032
MeSH IDM0057734

Synonyms (14)

Synonym
nsc-49061
21031-74-3
nsc49061
mls002667232 ,
1-cyclohexylthymine
smr001557001
HMS3089M19
2,4(1h,3h)-pyrimidinedione, 1-cyclohexyl-5-methyl-
unii-f71ly04j3w
nsc 49061
f71ly04j3w ,
DTXSID90175236
1-cyclohexyl-5-methyl-2,4(1h,3h)-pyrimidinedione
thymine, 1-cyclohexyl-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]